Genetik S.p.A.
UkraineAll drugs from this manufacturer
-
The drug is used for the treatment of bronchial asthma, exacerbations of chronic obstructive pulmonary disease (COPD), and very severe croup (subglottic laryngitis) in children that requires hospitalization.
Dosage form: suspension, for inhalation
Active substance Dosage budesonide 0.25 mg/ml ATC: R03BA02
-
The drug is used for the treatment of bronchial asthma, exacerbations of chronic obstructive pulmonary disease (COPD), and very severe croup (subglottic laryngitis) in children that requires hospitalization.
Dosage form: suspension, for inhalation
Active substance Dosage budesonide 0.5 mg/ml ATC: R03BA02
-
The drug is intended for the treatment of bronchial asthma in adults and children. It is also recommended for infants and children for the treatment of croup (laryngotracheobronchitis) requiring hospitalization.
Dosage form: suspension, for inhalation
Active substance Dosage budesonide 0.25 mg/ml ATC: R03BA02
-
The drug is indicated for the treatment of bronchial asthma in adults and children. It is also recommended for infants and children with croup (laryngotracheobronchitis) requiring hospitalization.
Dosage form: suspension, for inhalation
Active substance Dosage budesonide 0.50 mg/ml ATC: R03BA02